Australia - Inggris - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - sodium chloride, quantity: 5.786 g/l; chloride, quantity: 102.5 mmol/l; calcium chloride dihydrate, quantity: 0.1838 g/l; magnesium chloride hexahydrate, quantity: 0.1017 g/l; magnesium, quantity: 0.5 mmol/l; lactate, quantity: 35 mmol/l; sodium lactate, quantity: 3.925 g/l; glucose monohydrate, quantity: 25 g/l; calcium, quantity: 1.25 mmol/l; sodium, quantity: 134 mmol/l - solution, irrigation - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - for use as a peritoneal dialysis solution in the management of end stage renal disease and acute renal failure.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - chloride, quantity: 102.5 mmol/l; magnesium chloride hexahydrate, quantity: 0.1017 g/l; lactate, quantity: 35 mmol/l; magnesium, quantity: 0.5 mmol/l; calcium, quantity: 1.25 mmol/l; calcium chloride dihydrate, quantity: 0.1838 g/l; sodium chloride, quantity: 5.786 g/l; glucose monohydrate, quantity: 46.75 g/l; sodium lactate, quantity: 3.925 g/l; sodium, quantity: 134 mmol/l - solution, irrigation - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide - for use as a peritoneal dialysis solution in the management of end stage renal disease and acute renal failure.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

fresenius medical care australia pty ltd - glucose monohydrate, quantity: 16.5 g/l; magnesium chloride hexahydrate, quantity: 0.1017 g/l; calcium chloride dihydrate, quantity: 0.1838 g/l; lactate, quantity: 35 mmol/l; calcium, quantity: 1.25 mmol/l; chloride, quantity: 102.5 mmol/l; magnesium, quantity: 0.5 mmol/l; sodium lactate, quantity: 3.925 g/l; sodium, quantity: 134 mmol/l; sodium chloride, quantity: 5.786 g/l - solution, irrigation - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - for use as a peritoneal dialysis solution in the management of end stage renal disease and acute renal failure.

Malta - Inggris - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - calcium chloride, glucose monohydrate, magnesium chloride, hexahydrate, sodium chloride, sodium hydrogen, carbonate, sodium lactate - solution for peritoneal dialysis - calcium chloride 0.184 g/l glucose monohydrate 15 g/l magnesium chloride hexahydrate 0.051 g/l sodium chloride 5.38 g/l sodium hydrogen carbonate 2.1 g/l sodium lactate 1.68 g/l - blood substitutes and perfusion solutions

Malta - Inggris - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - sodium hydrogen, carbonate, sodium lactate, calcium chloride, glucose monohydrate, magnesium chloride, hexahydrate, sodium chloride - solution for peritoneal dialysis - sodium hydrogen carbonate 2.1 g/l sodium lactate 1.68 g/l calcium chloride 0.184 g/l glucose monohydrate 42.5 g/l magnesium chloride hexahydrate 0.051 g/l sodium chloride 5.38 g/l - blood substitutes and perfusion solutions

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - ondansetron hydrochloride dihydrate, quantity: 9.98 mg (equivalent: ondansetron, qty 8 mg) - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide; sodium chloride; sodium citrate dihydrate; citric acid monohydrate - ondansetron injection is indicated ? for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ? for the prevention and treatment of post-operative nausea and vomiting.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - ondansetron hydrochloride dihydrate, quantity: 4.99 mg (equivalent: ondansetron, qty 4 mg) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; citric acid monohydrate; sodium citrate dihydrate; hydrochloric acid; sodium chloride - ondansetron injection is indicated ? for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ? for the prevention and treatment of post-operative nausea and vomiting.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - olodaterol hydrochloride, quantity: 2.736 microgram/actuation (equivalent: olodaterol, qty 2.5 microgram/actuation); tiotropium bromide monohydrate, quantity: 3.124 microgram/actuation (equivalent: tiotropium, qty 2.5 microgram/actuation) - inhalation, conventional - excipient ingredients: purified water; benzalkonium chloride; hydrochloric acid; disodium edetate - spiolto respimat is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

Amerika Serikat - Inggris - NLM (National Library of Medicine)

general injectables & vaccines, inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - dextrose monohydrate 25 g in 50 ml - 50% dextrose injection is indicated in the treatment of insulin hypoglycemia (hyperinsulinemia or insulin shock) to restore blood glucose levels. the solution is also indicated, after dilution, for intravenous infusion as a source of carbohydrate calories in patients whose oral intake is restricted or inadequate to maintain nutritional requirements. slow infusion of hypertonic solutions is essential to insure proper utilization of dextrose and avoid production of hyperglycemia. a concentrated dextrose solution should not be used when intracranial or intraspinal hemorrhage is present, nor in the presence of delirium tremens if the patient is already dehydrated. dextrose injection without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

orion laboratories pty ltd t/a perrigo australia - chloral hydrate, quantity: 100 mg/ml - oral liquid, solution - excipient ingredients: sucrose; citric acid; sodium citrate dihydrate; saccharin sodium; glycerol; methyl hydroxybenzoate; ethanol; propylene glycol; purified water; flavour - indications as at 19 september 2003: chloral hydrate mixture is indicated pre-operatively to produce sedation. it is also indicated for short term (not more than 2 weeks) use as a hypnotic to assist in sleep disorders.